Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06538298 · ClinicalTrials.gov registry record · Early Phase 1
Title: A Multimodal Exercise Program With Gamification for Parkinson Disease (MEP+G)
A Early Phase 1 study of Parkinson Disease, sponsored by California State University, Northridge.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06538298: Recruiting Early Phase 1 study of Parkinson Disease, sponsored by California State University, Northridge.
NCT06538298 is a Early Phase 1 study of Parkinson Disease that is actively recruiting participants, run by California State University, Northridge. The registered enrollment target is 50 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06538298, a Early Phase 1 study of Parkinson Disease, is actively recruiting participants, sponsored by California State University, Northridge.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
In this pilot study the research will explore whether exercises and the outcome measures would be acceptable to conduct a more detailed research study. This 8 week pilot study will utilize a comprehensive exercise program that includes non-contact boxing along with computerized games for individuals with Parkinson Disease.
Conditions Studied
Interventions
- OTHER Multimodal Exercise Program with Gamification
Study Locations (1)
California
- Equilibrium Physical Therapy - Ventura
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-09-15 |
| Est. Completion | 2026-06-27 |
| Phase | Early Phase 1 |
What NCT06538298 shows while recruiting
NCT06538298 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Multimodal Exercise Program with Gamification is the first listed.
NCT06538298 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06538298 about?
NCT06538298 is a clinical study titled "Title: A Multimodal Exercise Program With Gamification for Parkinson Disease (MEP+G)". In this pilot study the research will explore whether exercises and the outcome measures would be acceptable to conduct a more detailed research study. This 8 week pilot study will utilize a comprehensive exercise program that includes non-contact boxing along with computerized games for individuals...
What is the current status of trial NCT06538298?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 50 participants. The study started on 2024-09-15. Estimated completion is 2026-06-27.
What conditions does trial NCT06538298 study?
This clinical trial studies the following conditions: Parkinson Disease.
What interventions are being tested in trial NCT06538298?
The interventions under investigation include: Multimodal Exercise Program with Gamification (OTHER).
Who is sponsoring clinical trial NCT06538298?
This trial is sponsored by California State University, Northridge, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06538298 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06538298's enrollment target sits among peer trials
50 155th of 297 higher than 135 of 297 other Parkinson Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients
RECRUITING · Early Phase 1
-
Multiple Objective Particle Swarm Optimization Postural Instability Gait Disorder
RECRUITING · Early Phase 1
-
Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease
RECRUITING · Early Phase 1
-
Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging)
RECRUITING · Early Phase 1
-
Quantitative Imaging of Brain Glymphatic Function in Humans
ACTIVE NOT RECRUITING · Early Phase 1
-
Evaluation of Neuroinflammation in Parkinson's Disease Using 18F-NOS PET/CT
ACTIVE NOT RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI